Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Depreciation & Amortization (CF) (2016 - 2026)

Nutex Health (NUTX) has disclosed Depreciation & Amortization (CF) for 17 consecutive years, with $5.5 million as the latest value for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 7.86% year-over-year to $5.5 million; the TTM value through Mar 2026 reached $20.9 million, up 5.29%, while the annual FY2025 figure was $20.5 million, 8.21% up from the prior year.
  • Depreciation & Amortization (CF) hit $5.5 million in Q1 2026 for Nutex Health, up from $5.2 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $5.5 million in Q1 2026 and bottomed at $2.4 million in Q1 2022.
  • Average Depreciation & Amortization (CF) over 5 years is $4.5 million, with a median of $4.7 million recorded in 2023.
  • On a YoY basis, Depreciation & Amortization (CF) climbed as much as 3642.52% in 2022 and fell as far as 20.45% in 2022.
  • Nutex Health's Depreciation & Amortization (CF) stood at $3.3 million in 2022, then skyrocketed by 43.13% to $4.7 million in 2023, then grew by 12.77% to $5.3 million in 2024, then dropped by 1.78% to $5.2 million in 2025, then grew by 5.88% to $5.5 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $5.5 million, $5.2 million, and $5.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.